Andere talen KPC Pharmaceuticals,Inc

Aandelen

600422

CNE0000015P8

slotkoers Shanghai S.E. Andere beurzen 00:00:00 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
21,39 ^CNY	+0,75%		-1,88%	+2,54%

19/04	KPC Pharmaceuticals,Inc rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
21/03	KPC Pharmaceuticals,Inc stelt dividend in contanten voor	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

KPC Pharmaceuticals,Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04
Kunyao Group Receives Clinical Trial Approval for FMF Drug	17/04
KPC Pharmaceuticals,Inc Proposes Cash Dividend	21/03
KPC Pharmaceuticals,Inc Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
KPC Pharmaceuticals,Inc Reports Earnings Results for the Nine Months Ended September 30, 2023	27-10-23
KPC Pharmaceuticals’ Antimalarial Drug Passes WHO Prequalification	13-10-23
KPC Pharmaceuticals' Attributable Profit Rises 3.1%; Shares Slip 4%	30-08-23
KPC Pharmaceuticals,Inc Reports Earnings Results for the Half Year Ended June 30, 2023	29-08-23
KPC Pharmaceuticals' Q1 Net Profit Jumps; Shares Rise 7%	28-04-23
KPC Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	27-04-23
KPC Pharma’s Shingles Drug Added to China’s Medical Insurance Catalog	20-01-23
KPC Pharma to Hold Phase II Clinical Trial of Stroke Drug	20-01-23
China Resources Pharmaceutical Completes Transfer of KPC Pharmaceutical Shares to Unit	03-01-23
KPC Pharmaceuticals CFO Steps Down	02-01-23
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. completed the acquisition of a 28% stake in KPC Pharmaceuticals, Inc. from Hofon Pharmaceuticals Co.,Ltd. and Holley Group Company Limited.	30-12-22
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	24-10-22
KPC Pharmaceuticals Unit Receives Marketing Authorization of Angong Niuhuang Pills; Shares Jump 7%	21-10-22
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	15-08-22
Chinese Shares Rebound; KPC Pharma Rallies 10% on CR Sanjiu’s $431 Million Stake Purchase	10-05-22
CR Sanjiu Medical & Pharma to Buy 28% Stake in KPC Pharma For $430 Million	10-05-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen KPC Pharmaceuticals,Inc

Aandelen

600422

CNE0000015P8

Andere talen

Filters